Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 7/19/2024Beijing to Build International Pharma Innovation Park
  • 7/19/2024Eli Lilly Wins Label Expansion for Tirzepatide in China
  • 7/19/2024Exscientia Acquires Full Control of CDK7 Drug, Plans Breast Cancer Com...
  • 7/19/2024Rona Thera Raises $35M Series A+ Financing to Advance Innovative Metab...
  • 7/19/2024ExoNeuglia Secures Investment to Advance Clinical Trials for Neurodege...
  • 7/18/2024Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...
  • 7/18/2024Marinus's Ganaxolone Approved in China as First Treatment for Seizures...
  • 7/18/2024India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
  • 7/17/2024Green Cross Sells Hong Kong Unit to China Resources Boya Bio
  • 7/17/2024SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to E...
  • 7/17/2024Full-Life Tech, SK Biopharma Enter Licensing Deal for Novel Therapeuti...
  • 7/16/2024U.S. Senators Introduce Bill to Reduce U.S. Dependence on China for Ph...
  • 7/15/2024GenScript's US Unit Legend Biotech Reportedly Receives Takeover Approa...
  • 7/12/2024AFT in China Distribution Deal with Hainan Haiyao for Skin Infection C...
  • 7/11/2024Sichuan Biokin Pharma Files for US$500M Hong Kong IPO
  • 7/11/2024Ipsen and ForeseenBio Strike Global Licensing Deal for ADCs with FIC...
  • 7/11/2024Eisai's Alzheimer's Drug LEQEMBI (Lecanemab) Approved in Hong Kong
  • 7/10/2024Novartis Expects to Maintain Double-digit Growth in China
  • 7/9/2024SciClone Pharma Completes Privatization
  • 7/9/2024Keymed Strikes Global Licensing Deal with Belenos
  • 7/8/2024State Council Approves the Implementation Plan for Supporting the Deve...
  • 7/8/2024Review of Innovative Drug Development Related Trends in China (H1/2024...
  • 7/3/2024CStone and Hengrui Enter into an Exclusive Promotion Deal of AYVAKIT i...
  • 7/3/2024LG Chem Launches Synovian in China
  • 7/3/2024Novartis Begins Construction of Its Second Manufacturing Site in China
  • 7/2/2024HanAll and HBM Resubmits BLA for Myasthenia Gravis Treatment in China
  • 7/2/2024BIOSECURE Act Impacts U.S. Biopharma Industry's Trust in Chinese Partn...
  • 7/2/2024Eisai and Biogen Launched Alzheimer's Drug LEQEMBI (Lecanemab) in Chin...
  • 7/1/2024Hasten Acquires Hasten 14 Legacy Products of Celltrion
  • 6/28/2024Financial-related Company News Digest (June 2024)
  • Page:18/21 Total number of articles:605: [First][<<] [16] [17] [18] [19] [20] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group